Näky Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.3/10
Näky falls below our bar on disclosure. Read the breakdown below before you give it money.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked August 2026
Pricing at steady state stays behind the intake. Näky holds LegitScript approval and sells compounded semaglutide and compounded tirzepatide, adds an oral semaglutide drops product that few others carry, runs a GLP-1 microdose program separately, and offers NAD+ and Sermorelin on top. Getting started means a 3-minute assessment online, after which a licensed provider returns a treatment plan the same day. For the oral line a NAKY10 promo code is referenced.
Is Näky legit?
Yes. Näky is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 6.3/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Näky promo or coupon code?
We know of no promo or coupon code for Näky. Its listed price is $145 a month. Coupon sites advertising "Näky discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Näky compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Näky
Trimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Näky at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $145/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Shipping
- FDA status
- No FDA warning letters found
How Näky scores
Six columns, each one computed from something Näky has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
6.8/10$145/month is 22% below the $185 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
3.0/10No price appears until the medical intake is finished.
Trust & Safety15%
4.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Näky
Last checked August 2026- Checked the listed price across 4 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Näky
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Näky involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Näky shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2Ask Näky which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes shipping.
- Lowest ongoing monthly price: semaglutide $145, tirzepatide $295. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that Näky serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
GLP-1 medications Näky offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Peptides Näky offers
Näky sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
Check the price yourself before you pay
Every figure here was read off Näky's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $145 a month, 22% below the $185 median for compounded semaglutide across the sellers we compare
- The monthly price stays the same as your dose goes up
- The monthly price includes shipping
- We found no FDA warning letters issued to Näky
Against it
- Tirzepatide costs $295 a month, 18% above the $250 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Näky charges
The standing price at Näky is $145/month, unchanged as the dose goes up. That sits at the affordable end of what we see. Flat dose pricing matters more than it sounds: on a tiered plan the bill grows with the dose, so the figure that got you to sign up is not the one you end up paying.
- Compounded semaglutide: $185/month
- Compounded tirzepatide: $295/month
- Compounded semaglutide: $145/month
- Brand-name semaglutide: $424/month
For compounded semaglutide, the median across the sellers we compare is $185/month, so Näky's $145 is genuinely below the middle, not just advertised that way.
Found, at about $149/month, is the closest like-for-like alternative we review.
What Näky dispenses
Näky prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. The choice is between an FDA-approved pen and a compounded preparation that costs less. Compounding is lawful and often appropriate, but a compounded product is not an approved one, and the price gap is largely that difference.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at Näky at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Safety and disclosure
Before you start an intake, ask Näky which states it serves, which pharmacy fills its prescriptions and what the monthly price includes. We found no FDA warning letters issued to Näky. The pharmacy question matters most here because the medication is compounded. If Näky will not name the pharmacy, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You need insurance to cover the cost. Check whether Näky bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want the price to stop moving as your dose climbs
- injections are the thing keeping you from starting
Our read
Näky competes on price: $145/month. The catch is disclosure, which is why Näky scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you.
The Bottom Line
Näky falls below our bar on disclosure. Read the breakdown below before you give it money.
Before you pay Näky
Starting at $145 a month. Check today's price, then start the intake.
Where Näky is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If the standing monthly cost is what decides it, consider Sesame Care (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare Näky head to head
The sellers closest to Näky on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Näky review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Näky's current pricing
Plans start at $145 a month. Whether you qualify is a clinician's decision, made after your intake.